spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Otsuka 

 HSMN NewsFeed - 12 May 2023
NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2023
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
Devices Neurology FDA
 HSMN NewsFeed - 4 Aug 2022
Amgen to Acquire Chemocentryx for $4 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 May 2022
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jul 2021
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2021
FDA Grants Breakthrough Therapy Designation for Taiho Oncology's Futibatinib for Treatment of Advanced Cholangiocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Dec 2020
ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise(TM) Ultrasound Renal Denervation System
Devices Cardiology FDA
 HSMN NewsFeed - 15 Sep 2020
Partner Therapeutics (PTx) Announces the Appointment of Ed Rock as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2019
Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2019
FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Feb 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Sep 2018
Halozyme Appoints Bernadette Connaughton To Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jun 2018
Replimune Appoints Dieter K. Weinand to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Apr 2018
Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 8 Jan 2018
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2018
Taiho Oncology Names Timothy Whitten President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Dec 2017
Mylan and Aspen Announce Launch of Generic Busulfex(R) Injection
Biopharmaceuticals Oncology Generics Product Launch
 HSMN NewsFeed - 18 Sep 2017
Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 24 Aug 2017
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba(TM)) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jul 2017
Novus Therapeutics Announces Change in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2017
Pharmavite Appoints Matthew Roberts to New Role of Executive Vice President, Chief Technical and Quality Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2017
Otsuka Pharmaceutical to Acquire Neurovance, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2016
ReCor Medical Announces Key Milestones in RADIANCE-HTN Hypertension Clinical Study
Devices Cardiology
 HSMN NewsFeed - 14 Sep 2016
DS Biopharma Announces the Appointment of Dr. Markus Weissbach as Chief Operating Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 9 Jun 2016
NuView Life Sciences Appoints Joel R. Timberlake as President of US Radiopharmaceuticals
Biopharmaceuticals Radiology Oncology Personnel
 HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Apr 2016
Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Mar 2016
Therabron Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Feb 2016
CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Oct 2015
OptiNose Closes New Round of Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 23 Dec 2014
Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer
Devices Monitoring Personnel
 HSMN NewsFeed - 2 Dec 2014
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2014
Otsuka Wins European Marketing Authorization for Deltyba(TM) (delamanid)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Mar 2014
Eisai Assigns Its Worldwide Exclusive License for DACOGEN(R) to Otsuka
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Mar 2014
Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 27 Dec 2013
European Medicines Agency (EMA) Accepts Otsuka's Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Dec 2013
Tyrosine Pharma Names Laslie President and CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Nov 2013
Otsuka and Lundbeck's Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Sep 2013
Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2011
PharmAthene Appoints Linda L. Chang Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2011
Acucela Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President, Regulatory Affairs & Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2010
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 16 Nov 2010
Otsuka Prevails in U.S. Abilify(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jul 2010
ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Nov 2009
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2009
Rexahn Promotes Rick Soni to President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2009
EKR Therapeutics Announces the Appointment of Dave Iwanicki as Senior Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2009
FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2008
MethylGene Reports Clinical Data for MGCD0103 at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Apr 2008
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Mar 2008
Abraxis Bioscience Announces Filing of Marketing Application in Japan for ABRAXANE in the Treatment of Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2007
New Drug Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Dec 2007
Otsuka Pharmaceutical Acquires Rights to IV Busulfex From PDL BioPharma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 20 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2007
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
Diagnostics Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2007
ARIAD Names Vice President, Clinical Operations to Further Enhance Global Clinical Development Efforts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
Nile Therapeutics, Inc. Adds to Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2007
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Jul 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 May 2007
Galenea Corp. Appoints Mark Benjamin as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2007
EVEREST Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Mar 2007
Valeant Pharmaceuticals Announces Resignation of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 27 Dec 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan
Biopharmaceuticals Endocrinology Licensing
 HSMN NewsFeed - 14 Dec 2006
CyDex Announces Captisol Technology Used in Recently Launched Injection Formulation of Antipsychotic Medication ABILIFY(R) (aripiprazole)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Dec 2006
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
Biopharmaceuticals
 HSMN NewsFeed - 7 Dec 2006
ABILIFY(R) (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2006
Otsuka Pharmaceutical Co., Ltd. Announces FDA Clearance for the RAPIRUN(R) H. pylori Antibody Detection Kit
Diagnostics FDA
 HSMN NewsFeed - 14 Nov 2006
Bristol-Myers Squibb Company Announces Promotion of Andrew Bonfield and Elliott Sigal to Executive Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2006
New Data on Otsuka's Investigational Product for Hyponatremia Presented at American Heart Association Annual Meeting
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Nov 2006
Napo Pharmaceuticals, Inc. ("Napo" or "the Company") Appointment of VP Clinical Affairs and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2006
Santarus and inVentiv Health Announce Agreement to Add Representatives to Santarus' ZEGERID Sales Team
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Aug 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY(R) DISCMELT(TM) (aripiprazole)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Aug 2006
FDA Approves ADEPT(R) Adhesion Reduction Solution [4% Icodextrin Solution]
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 25 May 2006
Six-Month Study Evaluated Effectiveness of Aripiprazole and Standard of Care In Management of Community-Treated Patients with Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2006
ABILIFY(R) (Aripiprazole) Demonstrated Efficacy as Maintenance Therapy In Adults with Bipolar I Disorder Following Treatment for a Recent Manic or Mixed Episode
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2006
Mylan Announces Final FDA Approval for Cilostazol Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Apr 2006
Neuronetics Prepares for Market Launch of New Depression Therapy; Hires Peter Anastasiou as Vice President, Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 28 Mar 2006
Santarus Announces U.S. Launch of ZEGERID Capsules
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 23 Feb 2006
Otsuka Maryland Research Institute, Inc. Granted Fast Track Designation for Tolvaptan in PKD
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Feb 2006
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. Announce Availability of 2 mg ABILIFY(R) (aripiprazole) Tablet and Nonrefrigerated Oral Solution
Biopharmaceuticals
 HSMN NewsFeed - 5 Jan 2006
Boston Life Sciences, Inc. Announces Appointment of Senior Vice President, Regulatory Affairs and Quality
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 41

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 41 additional stories matching:
Otsuka
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.